Today's legislative hearing focuses on three bills designed to improve the predictability and transparency in Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) regulation.
Editor's note · Context
Pitts outlines the focus of the legislative hearing on drug regulation improvements.
Share
More from Joe Pitts
Because of the Affordable Care Act, now over 20 million people in this country who were in that situation literally overnight are no longer in that situation.
Today's hearing will be taking a close look at the United States Preventive Services Task Force, created in 1984 as an independent, volunteer panel of 16 national experts in prevention, primary care, and evidence-based medicine and tasked…
I applaud the co-sponsors for working through the committee to address serious stakeholder concerns by taking a new approach in the draft we are discussing today.
Explicitly creating a program exclusively for catfish seems to be unnecessary, and it directs resources away from high-risk foods.





